-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 A1i7t9DfBwj8jnQHPZ8uGw866ihnHb1uA5fZczL4yyTSDy/22PF/oTht0EmtnOWG
 sRp3Hn2yjp2PsQAfLNKPsg==

<SEC-DOCUMENT>0001333263-09-000003.txt : 20091026
<SEC-HEADER>0001333263-09-000003.hdr.sgml : 20091026
<ACCEPTANCE-DATETIME>20091023180840
ACCESSION NUMBER:		0001333263-09-000003
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20091026
DATE AS OF CHANGE:		20091023
EFFECTIVENESS DATE:		20091026

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Novelix Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001333263
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-79381
		FILM NUMBER:		091135325

	BUSINESS ADDRESS:	
		STREET 1:		8008 GIRARD AVE.
		STREET 2:		SUITE 330
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		(858) 454-3245

	MAIL ADDRESS:	
		STREET 1:		8008 GIRARD AVE.
		STREET 2:		SUITE 330
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0603</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001333263</cik>
        <entityName>Novelix Pharmaceuticals Inc</entityName>
        <issuerAddress>
            <street1>8008 GIRARD AVE.</street1>
            <street2>SUITE 330</street2>
            <city>LA JOLLA</city>
            <stateOrCountry>CA</stateOrCountry>
            <zipCode>92037</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>(858) 454-3245</issuerPhoneNumber>
        <jurisdictionOfInc>DELAWARE</jurisdictionOfInc>
        <issuerPreviousNameList>
            <value>None</value>
        </issuerPreviousNameList>
        <edgarPreviousNameList>
            <value>None</value>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Burkhard</firstName>
                <lastName>Jansen</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Novelix Pharmaceuticals, Inc.</street1>
                <street2>8008 Girard Ave., Suite 330</street2>
                <city>La Jolla</city>
                <stateOrCountry>CA</stateOrCountry>
                <zipCode>92037</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Timothy</firstName>
                <lastName>Triche</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Novelix Pharmaceuticals, Inc.</street1>
                <street2>8008 Girard Ave., Ste. 330</street2>
                <city>La Jolla</city>
                <stateOrCountry>CA</stateOrCountry>
                <zipCode>92037</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Jeremy</firstName>
                <lastName>Teraoka</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Novelix Pharmaceuticals, Inc.</street1>
                <street2>8008 Girard Ave., Ste. 330</street2>
                <city>La Jolla</city>
                <stateOrCountry>CA</stateOrCountry>
                <zipCode>92037</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Pharmaceuticals</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Decline to Disclose</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2009-10-08</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>1750000</totalOfferingAmount>
            <totalAmountSold>253103</totalAmountSold>
            <totalRemaining>1496897</totalRemaining>
            <clarificationOfResponse>Offering of Series A-5 Preferred Stock and the underlying shares of Common Stock issued upon the conversion thereof.</clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>10</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse>Proceeds will be used for general working capital purposes</clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>Novelix Pharmaceuticals Inc</issuerName>
                <signatureName>/s/ Jeremy Teraoka</signatureName>
                <nameOfSigner>Jeremy Teraoka</nameOfSigner>
                <signatureTitle>Chief Financial Officer</signatureTitle>
                <signatureDate>2009-10-22</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----